newsfilter
← Latest News
Business Wire·

Vifor Pharma reports positive outcome of the phase-IIIb DIAMOND trial of Veltassa®

Phase-IIIb trial demonstrates statistically significant outcome on the primary endpoint Largest study to date showing benefit of Veltassa® (patiromer) in high risk patient population with heart failure Results suggest that treatment with Velt